Safety of Tirofiban in Acute Ischemic Stroke

Trial Profile

Safety of Tirofiban in Acute Ischemic Stroke

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Tirofiban (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Acronyms SaTIS
  • Most Recent Events

    • 18 Aug 2011 Results published in the Stroke.
    • 18 Aug 2011 Status changed from active, no longer recruiting to completed.
    • 06 Apr 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top